1 According to the two state receptor model, the b 2 -adrenergic receptor (b 2 -AR) isomerizes between an inactive state and a constitutively active state, which couples to the stimulatory Gprotein in the absence of agonist. In bovine tracheal smooth muscle (BTSM), we investigated the e ect of short and long term b 2 -AR activation by fenoterol on constitutive receptor activity. 2 Preincubation of the BTSM strips for 5 min, 30 min and 18 h with 10 mM fenoterol, followed by extensive washout (3 h, 378C), caused a rapid and time-dependent inhibition of KCl-induced contraction, reaching 68+10, 51+6 and 46+4% of control, respectively, at 40 mM KCl (P50.05 all). At all time points, the EC 50 values to KCl were signi®cantly reduced as well. 3 Preincubation of BTSM with 0.1, 1.0 and 10 mM fenoterol during 18 h caused a concentrationdependent decrease of the 40 mM KCl response to 70+5, 47+12 and 43+9% of control, respectively (P50.05 all). 4 The reduced KCl contractions were reversed in the presence of 1 mM timolol. Moreover, the sensitivity to KCl in the presence of timolol was enhanced after fenoterol incubation. Inverse agonism was also found for other b-blockers, with a rank order of e cacy of pindolol 5timolol=propranolol4alprenolol5sotalol4labetalol. 5 At 25 mM KCl-induced tone, the contraction induced by cumulative timolol administration was competitively antagonized by the less e cacious inverse agonist labetalol, indicating that the fenoterol-induced e ects cannot be explained by residual b-agonist binding. 6 In conclusion, fenoterol treatment of BTSM causes a time-and concentration-dependent development of constitutive b 2 -AR activity, which can be reversed by various inverse agonists. The b-agonist-induced changes could represent a novel regulation mechanism of b 2 -AR activity. British Journal of Pharmacology (2000) 131, 915 ± 920